Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PTCT compared with PLMR: revenue, margins and what each company keeps, and the suppliers and customers both name
PTCT
PTC Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PLMR
Palomar Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PTCT
PTC Therapeutics, Inc.
vs
PLMR
Palomar Holdings, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PLMR: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PTCT
13
PGEN
Precigen
supplier
IONS
Ionis Pharmaceuticals
supplier
NVS
Novartis Pharmaceuticals
customer
—
Akcea Therapeutics
unlisted
supplier
9 more · PTCT chain
›
Shared
0
No shared counterparties.
Only PLMR
6
—
Torrey Pines Re
unlisted
supplier
—
Federal Crop Insurance
unlisted
supplier
—
Federal Home Loan Bank of San Francisco (FHLB)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
A.M. Best
unlisted
supplier
2 more · PLMR chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PTCT, solid
PLMR, dashed
PTCT
PTC Therapeutics, Inc.
Change
69.36
▲
+1.82%
Mkt cap
$5.7B
Revenue
$361M
Q2 FY26
Revenue
$1.7B
FY25
PLMR
Palomar Holdings, Inc.
Change
143.59
▲
+0.97%
Regular session
Nov 4 '26
Mkt cap
$3.7B
Revenue
$309M
Q2 FY26
Revenue
$876M
FY25
vs
Compare
Regular session
Nov 4 '26
PTCT
PTC Therapeutics, Inc.
vs
PLMR
Palomar Holdings, Inc.
69.36
▲
+1.82%
Price
143.59
▲
+0.97%
$5.7B
Mkt cap
$3.7B
Q2 FY26
$361M
Revenue
$309M
Q2 FY26
FY25
$1.7B
Revenue
$876M
FY25
Change
Change
PTCT
69.36
▲
+1.82%
vs
PLMR
143.59
▲
+0.97%
Regular session
Nov 4 '26